Press Releases

01/07/2020 : The University of Tours and Theradiag sign two agreements simultaneously: an exclusive licensing agreement for the production of COVID-19 viral proteins and a global collaboration agreement that could lead to the creation of further partnerships

Croissy-Beaubourg, July, 1, 2020, 5:45 pm CEST – The University of Tours and THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for the French PEA-PME personal equity plan), a company specializing in in vitro diagnostics and theranostics,…

Continue Reading 01/07/2020 : The University of Tours and Theradiag sign two agreements simultaneously: an exclusive licensing agreement for the production of COVID-19 viral proteins and a global collaboration agreement that could lead to the creation of further partnerships

25/06/2020 : Theradiag: Combined General Meeting of shareholders of June 25, 2020 on second call – Voting results and resolutions

Croissy-Beaubourg, June 25, 2020 6:00 pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, informs its shareholders that its Combined General Meeting was held on second call…

Continue Reading 25/06/2020 : Theradiag: Combined General Meeting of shareholders of June 25, 2020 on second call – Voting results and resolutions

08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked

Croissy-Beaubourg, June 8, 8:15am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today provides an update on its new Covid-19 test program launched in response to the…

Continue Reading 08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked